Cargando…
Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy
SIMPLE SUMMARY: Application of drug delivery systems (DDS) in oncology may increase the effectiveness of cancer treatment and reduce the associated adverse side effects. Although various biomaterials can be considered for the development of DDS, the materials of natural origin offer great biocompati...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582423/ https://www.ncbi.nlm.nih.gov/pubmed/34771557 http://dx.doi.org/10.3390/cancers13215389 |
_version_ | 1784596982440919040 |
---|---|
author | Florczak, Anna Deptuch, Tomasz Kucharczyk, Kamil Dams-Kozlowska, Hanna |
author_facet | Florczak, Anna Deptuch, Tomasz Kucharczyk, Kamil Dams-Kozlowska, Hanna |
author_sort | Florczak, Anna |
collection | PubMed |
description | SIMPLE SUMMARY: Application of drug delivery systems (DDS) in oncology may increase the effectiveness of cancer treatment and reduce the associated adverse side effects. Although various biomaterials can be considered for the development of DDS, the materials of natural origin offer great biocompatibility and degradability. Silk is a natural biomaterial with exceptional properties, and one of them is the possibility to form diverse morphological structures. Scaffolds, films, hydrogels, fibers, foams spheres, capsules, microneedles, among others, can be used for local and systemic drug delivery. In this review, we described the various silk-based DDS for potential application in oncology. However, the unique silk properties combined with the possibility of their further modifications and blending open the gate to numerous potential biomedical applications, not only in the oncology field. ABSTRACT: For years, surgery, radiotherapy, and chemotherapy have been the gold standards to treat cancer, although continuing research has sought a more effective approach. While advances can be seen in the development of anticancer drugs, the tools that can improve their delivery remain a challenge. As anticancer drugs can affect the entire body, the control of their distribution is desirable to prevent systemic toxicity. The application of a suitable drug delivery platform may resolve this problem. Among other materials, silks offer many advantageous properties, including biodegradability, biocompatibility, and the possibility of obtaining a variety of morphological structures. These characteristics allow the exploration of silk for biomedical applications and as a platform for drug delivery. We have reviewed silk structures that can be used for local and systemic drug delivery for use in cancer therapy. After a short description of the most studied silks, we discuss the advantages of using silk for drug delivery. The tables summarize the descriptions of silk structures for the local and systemic transport of anticancer drugs. The most popular techniques for silk particle preparation are presented. Further prospects for using silk as a drug carrier are considered. The application of various silk biomaterials can improve cancer treatment by the controllable delivery of chemotherapeutics, immunotherapeutics, photosensitizers, hormones, nucleotherapeutics, targeted therapeutics (e.g., kinase inhibitors), and inorganic nanoparticles, among others. |
format | Online Article Text |
id | pubmed-8582423 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-85824232021-11-12 Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy Florczak, Anna Deptuch, Tomasz Kucharczyk, Kamil Dams-Kozlowska, Hanna Cancers (Basel) Review SIMPLE SUMMARY: Application of drug delivery systems (DDS) in oncology may increase the effectiveness of cancer treatment and reduce the associated adverse side effects. Although various biomaterials can be considered for the development of DDS, the materials of natural origin offer great biocompatibility and degradability. Silk is a natural biomaterial with exceptional properties, and one of them is the possibility to form diverse morphological structures. Scaffolds, films, hydrogels, fibers, foams spheres, capsules, microneedles, among others, can be used for local and systemic drug delivery. In this review, we described the various silk-based DDS for potential application in oncology. However, the unique silk properties combined with the possibility of their further modifications and blending open the gate to numerous potential biomedical applications, not only in the oncology field. ABSTRACT: For years, surgery, radiotherapy, and chemotherapy have been the gold standards to treat cancer, although continuing research has sought a more effective approach. While advances can be seen in the development of anticancer drugs, the tools that can improve their delivery remain a challenge. As anticancer drugs can affect the entire body, the control of their distribution is desirable to prevent systemic toxicity. The application of a suitable drug delivery platform may resolve this problem. Among other materials, silks offer many advantageous properties, including biodegradability, biocompatibility, and the possibility of obtaining a variety of morphological structures. These characteristics allow the exploration of silk for biomedical applications and as a platform for drug delivery. We have reviewed silk structures that can be used for local and systemic drug delivery for use in cancer therapy. After a short description of the most studied silks, we discuss the advantages of using silk for drug delivery. The tables summarize the descriptions of silk structures for the local and systemic transport of anticancer drugs. The most popular techniques for silk particle preparation are presented. Further prospects for using silk as a drug carrier are considered. The application of various silk biomaterials can improve cancer treatment by the controllable delivery of chemotherapeutics, immunotherapeutics, photosensitizers, hormones, nucleotherapeutics, targeted therapeutics (e.g., kinase inhibitors), and inorganic nanoparticles, among others. MDPI 2021-10-27 /pmc/articles/PMC8582423/ /pubmed/34771557 http://dx.doi.org/10.3390/cancers13215389 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Florczak, Anna Deptuch, Tomasz Kucharczyk, Kamil Dams-Kozlowska, Hanna Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy |
title | Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy |
title_full | Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy |
title_fullStr | Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy |
title_full_unstemmed | Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy |
title_short | Systemic and Local Silk-Based Drug Delivery Systems for Cancer Therapy |
title_sort | systemic and local silk-based drug delivery systems for cancer therapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582423/ https://www.ncbi.nlm.nih.gov/pubmed/34771557 http://dx.doi.org/10.3390/cancers13215389 |
work_keys_str_mv | AT florczakanna systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy AT deptuchtomasz systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy AT kucharczykkamil systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy AT damskozlowskahanna systemicandlocalsilkbaseddrugdeliverysystemsforcancertherapy |